Visit our news section for more articles.
News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events
Evernow Publishing Ltd Privacy Policy. Read more.
Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.
The latest MedNous journal. Subscribe to download.
Netherlands
A special purpose acquisition company, known colloquially as a blank cheque company, has been launched by Life Sciences Partners (LSP) of the Netherlands, the first such company to focus exclusively on European biotech. Special purpose acquisition companies, or SPACs, are proliferating on Wall Street, fuelled by low interest rates and a demand from investors for innovative assets.
Netherlands
UniQure NV has concluded an investigation of a patient who had a preliminary diagnosis of hepatocellular carcinoma (HCC) whilst participating in the gene therapy trial HOPE-B for haemophilia. In a statement issued on 29 March, the company said “it is highly unlikely the HCC was caused by etranacogene dezaparvovec.” The company has shared the data with the US Food and Drug Administration, which put a clinical hold on the trial in December 2020.
Germany
Medigene AG has reported the discovery of novel immunogenic tumour specific antigens derived from the non-coding regions of the human genome. The German biotech company presented the finding at the virtual annual meeting of the American Association for Cancer Research on 10 April.
United States
France
United States
Austria
United Kingdom
United Kingdom
Netherlands
Netherlands
France
Netherlands
Visit our news section for more articles.
News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events
© 2021 Evernow Publishing Ltd. Powered by Drupal.